173 related articles for article (PubMed ID: 24557330)
1. Long-term course after initial iron removal of iron excess in patients with dysmetabolic iron overload syndrome.
Bardou-Jacquet E; Lainé F; Morcet J; Perrin M; Guyader D; Deugnier Y
Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):418-21. PubMed ID: 24557330
[TBL] [Abstract][Full Text] [Related]
2. Metabolic and hepatic effects of bloodletting in dysmetabolic iron overload syndrome: A randomized controlled study in 274 patients.
Lainé F; Ruivard M; Loustaud-Ratti V; Bonnet F; Calès P; Bardou-Jacquet E; Sacher-Huvelin S; Causse X; Beusnel C; Renault A; Bellissant E; Deugnier Y;
Hepatology; 2017 Feb; 65(2):465-474. PubMed ID: 27685251
[TBL] [Abstract][Full Text] [Related]
3. [Diagnosis of iron overload syndrome].
Polunina TE; Maev IV
Eksp Klin Gastroenterol; 2010; (5):61-8. PubMed ID: 20731136
[TBL] [Abstract][Full Text] [Related]
4. Optimizing the diagnosis and the treatment of iron overload diseases.
Brissot P
Expert Rev Gastroenterol Hepatol; 2016; 10(3):359-70. PubMed ID: 26561304
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis of 5 patients with possible primary hemochromatosis].
Jacobs EM; de Vries RA; Elving LD; Stalenhoef AF; Swinkels DW
Ned Tijdschr Geneeskd; 2003 Apr; 147(14):666-70. PubMed ID: 12712652
[TBL] [Abstract][Full Text] [Related]
6. Liver iron overload is associated with elevated SHBG concentration and moderate hypogonadotrophic hypogonadism in dysmetabolic men without genetic haemochromatosis.
Gautier A; Lainé F; Massart C; Sandret L; Piguel X; Brissot P; Balkau B; Deugnier Y; Bonnet F
Eur J Endocrinol; 2011 Aug; 165(2):339-43. PubMed ID: 21646287
[TBL] [Abstract][Full Text] [Related]
7. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
Busca A; Falda M; Manzini P; D'Antico S; Valfrè A; Locatelli F; Calabrese R; Chiappella A; D'Ardia S; Longo F; Piga A
Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730
[TBL] [Abstract][Full Text] [Related]
8. Phlebotomy-mobilized iron as a surrogate for liver iron content in hemochromatosis patients.
Phatak PD; Barton JC
Hematology; 2003 Dec; 8(6):429-32. PubMed ID: 14668040
[TBL] [Abstract][Full Text] [Related]
9. Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 μg/L at diagnosis.
Barton JC; Barton JC; Acton RT; So J; Chan S; Adams PC
Clin Gastroenterol Hepatol; 2012 Apr; 10(4):412-6. PubMed ID: 22265917
[TBL] [Abstract][Full Text] [Related]
10. Hemochromatosis and iron-overload screening in a racially diverse population.
Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
[TBL] [Abstract][Full Text] [Related]
11. Education and Imaging: Hepatobiliary and pancreatic: venesection for hemochromatosis.
Yap P; Hunt R; Das D
J Gastroenterol Hepatol; 2011 May; 26(5):934. PubMed ID: 21488950
[No Abstract] [Full Text] [Related]
12. Venesection therapy of insulin resistance-associated hepatic iron overload.
Guillygomarc'h A; Mendler MH; Moirand R; Lainé F; Quentin V; David V; Brissot P; Deugnier Y
J Hepatol; 2001 Sep; 35(3):344-9. PubMed ID: 11592595
[TBL] [Abstract][Full Text] [Related]
13. [Comparison between phlebotomy and erythrocytapheresis of iron overload in patients with HFE gene mutations].
Fernández-Mosteirín N; Salvador-Osuna C; García-Erce JA; Orna E; Pérez-Lungmus G; Giralt M
Med Clin (Barc); 2006 Sep; 127(11):409-12. PubMed ID: 17020684
[TBL] [Abstract][Full Text] [Related]
14. Severity of iron overload of proband determines serum ferritin levels in families with HFE-related hemochromatosis: the HEmochromatosis FAmily Study.
Jacobs EM; Hendriks JC; van Deursen CT; Kreeftenberg HG; de Vries RA; Marx JJ; Stalenhoef AF; Verbeek AL; Swinkels DW
J Hepatol; 2009 Jan; 50(1):174-83. PubMed ID: 19008010
[TBL] [Abstract][Full Text] [Related]
15. Patient compliance with phlebotomy therapy for iron overload associated with hemochromatosis.
Hicken BL; Tucker DC; Barton JC
Am J Gastroenterol; 2003 Sep; 98(9):2072-7. PubMed ID: 14499790
[TBL] [Abstract][Full Text] [Related]
16. Effects of phlebotomy therapy on cytochrome P450 2e1 activity and oxidative stress markers in dysmetabolic iron overload syndrome: a randomized trial.
Lainé F; Reymann JM; Morel F; Langouët S; Perrin M; Guillygomarc'h A; Brissot P; Turmel V; Mouchel C; Pape D; Bellissant E; Deugnier Y
Aliment Pharmacol Ther; 2006 Oct; 24(8):1207-13. PubMed ID: 17014579
[TBL] [Abstract][Full Text] [Related]
17. Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Kamble RT; Selby GB; Mims M; Kharfan-Dabaja MA; Ozer H; George JN
Biol Blood Marrow Transplant; 2006 May; 12(5):506-10. PubMed ID: 16635785
[TBL] [Abstract][Full Text] [Related]
18. Iron overload and prolonged ingestion of iron supplements: clinical features and mutation analysis of hemochromatosis-associated genes in four cases.
Barton JC; Lee PL; West C; Bottomley SS
Am J Hematol; 2006 Oct; 81(10):760-7. PubMed ID: 16838333
[TBL] [Abstract][Full Text] [Related]
19. [Hereditary iron overload].
Brissot P; Bardou-Jacquet E; Latournerie M; Ropert-Bouchet M; Island ML; Loréal O; Jouanolle AM
Pathol Biol (Paris); 2010 Oct; 58(5):316-23. PubMed ID: 19942367
[TBL] [Abstract][Full Text] [Related]
20. A diagnostic approach to hyperferritinemia with a non-elevated transferrin saturation.
Adams PC; Barton JC
J Hepatol; 2011 Aug; 55(2):453-8. PubMed ID: 21354228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
